清脆的
表型
生物
癌症研究
癌细胞
激酶
Cas9
细胞生物学
调节器
基因
癌症
遗传学
作者
Devikala Gurusamy,Amanda N. Henning,Tori N. Yamamoto,Zhiya Yu,Nikolaos Zacharakis,Sri Krishna,Rigel J. Kishton,Suman K. Vodnala,Arash Eidizadeh,Li Jia,Christine M. Kariya,Mary A. Black,Robert Eil,Douglas C. Palmer,Jenny H. Pan,Madhusudhanan Sukumar,Shashank J. Patel,Nicholas P. Restifo
出处
期刊:Cancer Cell
[Cell Press]
日期:2020-06-01
卷期号:37 (6): 818-833.e9
被引量:132
标识
DOI:10.1016/j.ccell.2020.05.004
摘要
Summary T cells are central to all currently effective cancer immunotherapies, but the characteristics defining therapeutically effective anti-tumor T cells have not been comprehensively elucidated. Here, we delineate four phenotypic qualities of effective anti-tumor T cells: cell expansion, differentiation, oxidative stress, and genomic stress. Using a CRISPR-Cas9-based genetic screen of primary T cells we measured the multi-phenotypic impact of disrupting 25 T cell receptor-driven kinases. We identified p38 kinase as a central regulator of all four phenotypes and uncovered transcriptional and antioxidant pathways regulated by p38 in T cells. Pharmacological inhibition of p38 improved the efficacy of mouse anti-tumor T cells and enhanced the functionalities of human tumor-reactive and gene-engineered T cells, paving the way for clinically relevant interventions.
科研通智能强力驱动
Strongly Powered by AbleSci AI